Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 1417947
[patent_doc_number] => 06518278
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-11
[patent_title] => 'Carcinostatic substance for compatible administration, process of administrating same and process of rapidly inspecting same'
[patent_app_type] => B1
[patent_app_number] => 09/496603
[patent_app_country] => US
[patent_app_date] => 2000-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 8750
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/518/06518278.pdf
[firstpage_image] =>[orig_patent_app_number] => 09496603
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/496603 | Carcinostatic substance for compatible administration, process of administrating same and process of rapidly inspecting same | Feb 1, 2000 | Issued |
Array
(
[id] => 1355768
[patent_doc_number] => 06576621
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-10
[patent_title] => 'Preparation of thioarabinofuranosyl compounds and use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/493247
[patent_app_country] => US
[patent_app_date] => 2000-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 8540
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/576/06576621.pdf
[firstpage_image] =>[orig_patent_app_number] => 09493247
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/493247 | Preparation of thioarabinofuranosyl compounds and use thereof | Jan 27, 2000 | Issued |
Array
(
[id] => 1337972
[patent_doc_number] => 06593353
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-15
[patent_title] => 'p53 inhibitors and therapeutic use of the same'
[patent_app_type] => B1
[patent_app_number] => 09/493527
[patent_app_country] => US
[patent_app_date] => 2000-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 28
[patent_no_of_words] => 10884
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/593/06593353.pdf
[firstpage_image] =>[orig_patent_app_number] => 09493527
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/493527 | p53 inhibitors and therapeutic use of the same | Jan 27, 2000 | Issued |
Array
(
[id] => 6669527
[patent_doc_number] => 20030114511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties'
[patent_app_type] => new
[patent_app_number] => 09/492531
[patent_app_country] => US
[patent_app_date] => 2000-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3067
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114511.pdf
[firstpage_image] =>[orig_patent_app_number] => 09492531
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/492531 | Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties | Jan 26, 2000 | Issued |
Array
(
[id] => 4305406
[patent_doc_number] => 06326376
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Anhydrovinblastine for the treatment of cancer'
[patent_app_type] => 1
[patent_app_number] => 9/380540
[patent_app_country] => US
[patent_app_date] => 2000-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 9000
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326376.pdf
[firstpage_image] =>[orig_patent_app_number] => 380540
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/380540 | Anhydrovinblastine for the treatment of cancer | Jan 20, 2000 | Issued |
Array
(
[id] => 1495702
[patent_doc_number] => 06403634
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-11
[patent_title] => 'Use of taxoid derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/482015
[patent_app_country] => US
[patent_app_date] => 2000-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4552
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 509
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/403/06403634.pdf
[firstpage_image] =>[orig_patent_app_number] => 09482015
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/482015 | Use of taxoid derivatives | Jan 12, 2000 | Issued |
Array
(
[id] => 1514803
[patent_doc_number] => 06420371
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-16
[patent_title] => 'Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies'
[patent_app_type] => B1
[patent_app_number] => 09/479660
[patent_app_country] => US
[patent_app_date] => 2000-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 28
[patent_no_of_words] => 8212
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/420/06420371.pdf
[firstpage_image] =>[orig_patent_app_number] => 09479660
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/479660 | Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies | Jan 9, 2000 | Issued |
Array
(
[id] => 1545767
[patent_doc_number] => 06444658
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Prevention of ovarian cancer by administration of a vitamin D compound'
[patent_app_type] => B1
[patent_app_number] => 09/479021
[patent_app_country] => US
[patent_app_date] => 2000-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7523
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444658.pdf
[firstpage_image] =>[orig_patent_app_number] => 09479021
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/479021 | Prevention of ovarian cancer by administration of a vitamin D compound | Jan 6, 2000 | Issued |
Array
(
[id] => 1470190
[patent_doc_number] => 06407082
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Prevention of ovarian cancer by administration of a vitamin D compound'
[patent_app_type] => B1
[patent_app_number] => 09/479837
[patent_app_country] => US
[patent_app_date] => 2000-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7541
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/407/06407082.pdf
[firstpage_image] =>[orig_patent_app_number] => 09479837
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/479837 | Prevention of ovarian cancer by administration of a vitamin D compound | Jan 6, 2000 | Issued |
Array
(
[id] => 1494529
[patent_doc_number] => 06342490
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-29
[patent_title] => 'Pharmaceutical composition containing uscharidin or its analogues'
[patent_app_type] => B1
[patent_app_number] => 09/423358
[patent_app_country] => US
[patent_app_date] => 2000-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 57
[patent_no_of_words] => 3971
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/342/06342490.pdf
[firstpage_image] =>[orig_patent_app_number] => 09423358
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/423358 | Pharmaceutical composition containing uscharidin or its analogues | Jan 4, 2000 | Issued |
09/462243 | HIV AND CANCER TREATMENT | Jan 4, 2000 | Abandoned |
Array
(
[id] => 6814287
[patent_doc_number] => 20030073837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => '3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATING PROTEIN KINASE ACTIVITY AND FOR USE IN CANCER CHEMOTHERAPY'
[patent_app_type] => new
[patent_app_number] => 09/476232
[patent_app_country] => US
[patent_app_date] => 1999-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36865
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073837.pdf
[firstpage_image] =>[orig_patent_app_number] => 09476232
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/476232 | 3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATING PROTEIN KINASE ACTIVITY AND FOR USE IN CANCER CHEMOTHERAPY | Dec 29, 1999 | Abandoned |
09/470951 | ANTIANGIOGENIC COMBITION THERAPY FOR THE TREATMENT OF CANCER | Dec 21, 1999 | Abandoned |
Array
(
[id] => 4410636
[patent_doc_number] => 06228876
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Pharmaceutical composition for inhibiting the growth of cancers'
[patent_app_type] => 1
[patent_app_number] => 9/469389
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2999
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228876.pdf
[firstpage_image] =>[orig_patent_app_number] => 469389
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/469389 | Pharmaceutical composition for inhibiting the growth of cancers | Dec 21, 1999 | Issued |
Array
(
[id] => 4409739
[patent_doc_number] => 06310054
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Prevention of ovarian cancer by administration of progestin products'
[patent_app_type] => 1
[patent_app_number] => 9/464899
[patent_app_country] => US
[patent_app_date] => 1999-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7735
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/310/06310054.pdf
[firstpage_image] =>[orig_patent_app_number] => 464899
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/464899 | Prevention of ovarian cancer by administration of progestin products | Dec 15, 1999 | Issued |
Array
(
[id] => 4304191
[patent_doc_number] => 06251886
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Methods of using temozolomide in the treatment of cancers'
[patent_app_type] => 1
[patent_app_number] => 9/453747
[patent_app_country] => US
[patent_app_date] => 1999-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6872
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/251/06251886.pdf
[firstpage_image] =>[orig_patent_app_number] => 453747
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/453747 | Methods of using temozolomide in the treatment of cancers | Dec 1, 1999 | Issued |
09/367806 | USE OF 9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3-DIOL, OR ALFACALCIDOL | Nov 28, 1999 | Abandoned |
Array
(
[id] => 1373955
[patent_doc_number] => 06562830
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-13
[patent_title] => 'Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/436806
[patent_app_country] => US
[patent_app_date] => 1999-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8880
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/562/06562830.pdf
[firstpage_image] =>[orig_patent_app_number] => 09436806
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/436806 | Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives | Nov 8, 1999 | Issued |
Array
(
[id] => 4349761
[patent_doc_number] => 06214803
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Pharmacological composition for treating cancer cells'
[patent_app_type] => 1
[patent_app_number] => 9/435521
[patent_app_country] => US
[patent_app_date] => 1999-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 20
[patent_no_of_words] => 4943
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214803.pdf
[firstpage_image] =>[orig_patent_app_number] => 435521
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/435521 | Pharmacological composition for treating cancer cells | Nov 7, 1999 | Issued |
09/367435 | FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG COA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER | Oct 24, 1999 | Abandoned |